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Abstract
Background: An increase in intracellular calcium concentration [Ca2+]i is one of the first events to take place after
brain ischemia. A key [Ca2+]i-regulated signaling molecule is the phosphatase calcineurin (CN), which plays
important roles in the modulation of inflammatory cascades. Here, we have analyzed the role of endogenous
regulator of CN 1 (Rcan1) in response to experimental ischemic stroke induced by middle cerebral artery occlusion.
Methods: Animals were subjected to focal cerebral ischemia with reperfusion. To assess the role of Rcan1 after
stroke, we measured infarct volume after 48 h of reperfusion in Rcan1 knockout (KO) and wild-type (WT) mice. In
vitro studies were performed in astrocyte-enriched cortical primary cultures subjected to 3% oxygen (hypoxia) and
glucose deprivation (HGD). Adenoviral vectors were used to analyze the effect of overexpression of Rcan1-4
protein. Protein expression was examined by immunohistochemistry and immunoblotting and expression of mRNA
by quantitative real-time Reverse-Transcription Polymerase Chain Reaction (real time qRT-PCR).
Results: Brain ischemia/reperfusion (I/R) injury in vivo increased mRNA and protein expression of the calcium-inducible
Rcan1 isoform (Rcan1-4). I/R-inducible expression of Rcan1 protein occurred mainly in astroglial cells, and in an in vitro
model of ischemia, HGD treatment of primary murine astrocyte cultures induced Rcan1-4 mRNA and protein
expression. Exogenous Rcan1-4 overexpression inhibited production of the inflammatory marker cyclo-oxygenase 2.
Mice lacking Rcan1 had higher expression of inflammation associated genes, resulting in larger infarct volumes.
Conclusions: Our results support a protective role for Rcan1 during the inflammatory response to stroke, and
underline the importance of the glial compartment in the inflammatory reaction that takes place after ischemia.
Improved understanding of non-neuronal mechanisms in ischemic injury promises novel approaches to the
treatment of acute ischemic stroke.
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Background
Stroke is a leading cause of human death and disability.
However, despite the prevalence and consequences of
brain ischemia the only effective treatment is to rein-
state the blood supply, a course of action available in
less than 3% of patients. Cerebral ischemia triggers a
marked inflammatory reaction that involves local cellu-
lar activation in the brain and production of inflamma-
tory mediators, including cytokines, chemokines,
proteases, reactive oxygen species and vascular adhesion
molecules (reviewed in [1]). Increased production of
proinflammatory cytokines and chemokines has been
detected in experimental models of brain ischemia, and
in humans after stroke [2,3]. During focal ischemia, the
cytokines interleukin 1b (IL-1b) and tumor necrosis fac-
tor a (TNFa) are generated very early and are secreted
by cells within and around the injured territory [4].
Astrocytes are an efficient source of inflammatory med-
iators such as TNFa, granulocyte macrophage colony
stimulating factor (GM-CSF), and others (reviewed in
[5,6]). Expression of these factors can cause further acti-
vation of microglial, neuronal and endothelial cells, per-
petuating immune/inflammatory signaling cycles if they
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are not halted by endogenous or exogenous anti-inflam-
matory agents.
One of the first events triggered by brain ischemia is
an overload of intracellular calcium [Ca2+]i [7]. A key
element of the cellular response to Ca2+ signals is the
phosphatase calcineurin (CN). The main mode of action
characterized for CN is the regulation of the nuclear
factor of activated T cells (NFAT) family of transcrip-
tion factors (reviewed in [8,9]). Endogenous regulation
of CN is mediated by members of the regulator of calci-
neurin (Rcan) family, previously named Down syndrome
critical region (DSCR), modulatory calcineurin interact-
ing protein (MCIP), calcipressin and Adapt78 in mam-
mals [10,11]. The most studied Rcan member in
mammals, and the only one regulated by Ca/CN, is
Rcan1. There are two main Rcan1 protein isoforms,
Rcan1-1 (252 amino acids) and Rcan1-4 (197 amino
acids), resulting from differential promoter use and first
exon choice [10]. Rcan1-4 is upregulated by increases in
[Ca2+]i in several cell types, including brain cells, via a
CN/NFAT-dependent pathway [12-16].
Rcan1 is highly expressed in brain [17], and elevated
expression of Rcan1 transcript and protein in the brains
of Down syndrome fetuses and Alzheimer patients has
been described [18,19], as well as reduced Rcan1-1
expression in Huntington disease [19,20]. Rcan1 is also
associated with oxidative stress [21,22], which together
with its sensitivity to calcium suggests a possible impli-
cation in brain ischemia. Recent evidence indicates that
Rcan1 is upregulated around the infarct area after
experimental stroke [23]; however, the role of Rcan1 in
the response to brain ischemia and calcium overload is
unknown.
In the present work, we investigate the role of Rcan1
protein in response to brain ischemia. We report that
Rcan1-4 protein and mRNA accumulate in brain cortex
early after ischemia/reperfusion, mainly in glial fibrillary
acidic protein (GFAP)-positive cells, and that Rcan1
deficiency worsens stroke outcome and increases expres-
sion of inflammation-associated genes. These findings
suggest protective roles for Rcan1 during brain ischemia
and neuropathologies with an inflammatory component.
Materials and methods
Models of transient focal cerebral ischemia
All animal procedures were performed in compliance
with European Community law 86/609/ECC and were
approved by the Ethics Committees of the Instituto de
Salud Carlos III and the Universidad Complutense de
Madrid.
For procedures in rat, adult male Fischer rats (275 to
300 g) were anesthetized with 1.5% isoflurane in a mix-
ture of 70% nitrogen/30% oxygen. Rats in which the
middle cerebral artery (MCA) and both common carotid
arteries (CCA) were exposed but not occluded served as
sham-operated controls. The femoral artery was cannu-
lated for continuous monitoring of arterial pressure and
blood sampling for analysis of pH, gases and glucose.
Body and brain temperature was maintained at 36.5 ±
0.5°C throughout the procedure. Monitored physiologi-
cal variables did not differ significantly between groups
of animals before, during or after middle cerebral artery
occlusion (MCAO) (data not shown). The surgical pro-
cedure was a variant of that previously described [24,25].
For procedures in mouse, 2-month-old adult male
wild-type and Rcan1 knockout (KO) C57BL6 mice
weighing 28 to 30 g were used. The KO strain has been
described elsewhere [26], and was backcrossed into the
C57BL6 background for more than 20 generations. Oli-
gonucleotide primers used for genotyping analysis were
5’-GGTGGTCCACGTGTGTGAGA-3’ and 5’-ACGT-
GAACAAAGGCTGGTCCT-3’. Mice were subjected to
transient focal cerebral ischemia through a combination
of both MCAO and ipsilateral common carotid artery
occlusion (CCAO) for 90 minutes, followed by disocclu-
sion of the two vessels and reperfusion for 48 h.
For protein extracts and RNA preparation, tissue sam-
ples were dissected from the ischemic brain region
around the occluded MCA and from the corresponding
non-infarcted region in the contralateral hemisphere
and rapidly frozen. For immunohistochemistry, rats
were deeply anesthetized (see above) 24 h after blood
reperfusion and then perfused intracardially with 4%
paraformaldehyde in phosphate buffer (PB, pH 7.4). The
brains were removed immediately and post fixed over-
night at 4°C in the same fixative. Brains were then cryo-
protected by incubation in 30% sucrose in PB for 48 to
72 h at 4°C. Frozen coronal sections (50 μm) were cut
with a freezing microtome (Leica, SM2000R) and pro-
cessed for immunohistochemistry.
Measurement of infarct volume
The infarct volume was estimated on Nissl-stained coronal
sections using Cavalieri’s principle [27]. Volume measure-
ments were calculated using the ‘contour’ and ‘Cavalieri
estimator probe’ of the Stereo Investigator software pack-
age. The spared tissue in the damaged hemisphere and the
contralateral hemisphere were outlined. The software then
randomly placed a quadratic grid of points over these
areas. Each grid point thus represents an area. The pro-
gram was used to estimate the area of the contours from
the number of selected grid points. The associated volume
was calculated by multiplying the area by the mean section
thickness. The precision of the volume estimate for each
brain was determined by computing the coefficient of
error for the estimates. The ratio between the volume of
the spared cortex in the damaged hemisphere (RN) and
that in the whole tissue of the contralateral hemisphere
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(L) was calculated, and used to detect differences in the
amount of cortex that was damaged by the infarct in each
animal. When expressed as a percentage, this ratio indi-
cates the percentage fraction of tissue spared from the
ischemia; therefore the percent of neocortex that was
infarcted (%I) is readily obtained by the formula %I =
(1 - (RN/L)) ×100.
Immunohistochemistry
Infarcted tissue in the neocortex was identified by stain-
ing slide-mounted coronal sections with Nissl (0.2% (w/
v) cresyl violet). Adjacent sections were then processed
for immunohistochemistry. Sections were permeabilized
and blocked for 3 h at room temperature by incubation
with 0.4% (v/v) Triton X-100 in Tris-buffered saline
(TBS) containing 10% (v/v) normal serum from the spe-
cies in which the secondary antibody was raised. Pri-
mary antibody was diluted in 0.2% (v/v) Triton X-100 in
TBS containing 4% (v/v) of the same serum used for
blocking. Goat polyclonal anti-GFAP antibody (Santa
Cruz Biotechnology, Inc Santa Cruz, CA, USA, sc-6170)
was diluted 1:500, and rabbit polyclonal Rcan1 antibody
[26] was diluted 1:100. Sections were incubated with pri-
mary antibody overnight at 4°C. After several washes in
TBS the sections were incubated for 2 h at room tem-
perature with secondary antibodies: Cy3-conjugated
anti-goat IgG or Alexa Fluor 488-conjugated anti-rabbit
IgG, (Invitrogen, Grand Island, NY, USA, 1:200). After
washing, sections were counterstained for 20 minutes at
room temperature with TO-PRO 3 iodide (Molecular
Probes) before mounting in Fluor-mount-G solution
(Southern Biotech Birmingham, AL, USA). Parallel con-
trols performed without primary antibodies showed very
low levels of non-specific staining. Confocal images
were acquired with a TCSSP5 confocal microscope
(Leica Microsystems GmbH, Wetzlar, Germany).
Cell culture and reagents
Cortical primary cultures enriched in astrocytes were
prepared as described [28]. Cortical astrocyte cultures
were plated at 4 × 105 cells per well in six-well plates or
1 × 106 cells per 10 cm2 plate and grown to confluence,
with medium changes every 3 days. After 17 to 20 days
in culture, immunocytochemical analysis indicated that
> 98% of the cells in the culture were GFAP positive.
The Ca2+ ionophore A23187 was from Merck Bios-
ciences Darmstadt, Germany. Phorbol 12myristate 13-
acetate (PMA) was from Sigma-Aldrich St. Louis, MO,
USA. Cyclosporin A (CsA) was from LC Laboratories
Woburn, MA, USA..
Hypoxia plus glucose deprivation (HGD) in vitro
Confluent primary astrocyte cultures were quiesced in Dul-
becco’s modified Eagle medium (DMEM) containing 0.5%
fetal calf serum (FCS) overnight. Cultures were then sub-
jected to hypoxia and deprived of glucose by incubation for
1 h in glucose-free DMEM (Life Technologies Corporation
Carlsbad, CA, USA) plus 0.5% FCS in an anaerobic cham-
ber (COY LaboratoryGrass Lake, MI, USA) in an atmo-
sphere of 3% oxygen and 5% CO2 balanced with nitrogen.
At the end of the required incubation period, cells were
lysed and frozen inside the chamber.
Cell lysis and immunoblot analysis
For whole-cell extracts, cells grown and stimulated in six-
well plates or as indicated were washed twice with cold
PBS and lysed for 30 minutes on ice in 100 μl hypertonic
buffer with occasional mild agitation, as described [13].
Total tissue extracts were obtained by homogenizing the
tissue in hypertonic buffer as before. Lysates were centri-
fuged for 10 minutes at 13,000 g, and the protein content
of supernatants, containing cytosolic and most nuclear
proteins, was quantified by Bio-Rad detergent-compatible
protein reagent (Hercules, CA, USA). Total extracts were
then boiled in 1× Laemmli buffer and resolved by 10% or
6% SDS-PAGE. Proteins were transferred to nitrocellu-
lose membranes that were then immunoblotted as
described [13]. The following antibodies were used: anti-
NFATc3 polyclonal M75 (Santa Cruz Biotechnology, Inc
Santa Cruz, CA, USA, sc-8321), monoclonal anti-a-tubu-
lin (Sigma-Aldrich St. Louis, MO, USA, T8203), mono-
clonal Rcan1-4, raised and described by Minami et al.
[15], and polyclonal Rcan1 antibody, raised and described
by Porta et al. [26].
RNA isolation, reverse transcription, and real-time PCR
Extraction of total RNA from rat or mouse cortical
astrocyte cultures and analysis of differential gene
expression by quantitative real-time Reverse-Transcrip-
tion Polymerase Chain Reaction (real time qRT-PCR)
were as described previously [13]. 18S rRNA and
TATA-binding protein (TBP) transcripts were used as
internal control genes and were amplified in the same
tube to normalize for variation in input RNA. The
amounts of target mRNA in samples was estimated by
the 2-ΔΔCT relative quantification method [29]. Ratios
were calculated between the amounts of mRNA from
stimulated and non-stimulated control cells.
Adenoviral infection of astrocytes
The adenovirus bicistronically encoding green fluores-
cent protein (GFP) and human Rcan1-4 (Ad Rcan1-4)
and the control adenovirus encoding GFP alone (Ad
GFP) were as described [15]. Adenoviruses were gener-
ated and purified following standard protocols. Adeno-
viral infection was carried out on subconfluent primary
astrocytes, and expression of the encoded protein was
monitored by immunoblot.
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Calcineurin phosphatase activity assay
CN enzyme activity in brain tissue was analyzed with
the Biomol Green Calcineurin Assay kit (Biomol, Ply-
mouth, PA, USA) according to the manufacturer’s
instructions. Soluble protein extracts from three inde-
pendent animals of each genetic background (Rcan1
wild-type (WT) and Rcan1 knockout (KO)) were pre-
pared by homogenizing the tissue samples on ice in lysis
buffer containing protein inhibitors. Soluble cytoplasmic
proteins were prepared by ultracentrifugation (100,000 g
for 45 minutes at 4°C). Excess sample phosphate was
removed by passing samples through freshly prepared
columns containing desalting resin (Bio-Rad, Hercules,
CA, USA). To measure calcineurin phosphatase activity,
protein extracts were quantified and equal protein
amounts incubated for 30 minutes according to the
assay kit instructions; liberated phosphate was measured
colorimetrically at 620 nm. Calcineurin activity was cal-
culated by comparison with a phosphate (PO4) standard
curve.
Statistical analysis
Results are expressed as the mean ± SEM or mean ± SD of
the indicated number of experiments. Statistical analysis
was by one-way analysis of variance (ANOVA) followed
by individual comparisons of means (Student’s t, New-
man-Keuls or Bonferroni tests). Values were considered
statistically significant at P < 0.05 (*) and P < 0.01 (**).
Results
Rcan1-4 protein is induced in murine models of brain
ischemia/reperfusion injury
The possible accumulation of Rcan1-4 protein in
response to ischemia/reperfusion (I/R) brain injury was
examined in a rat model. Ischemia was induced by
MCAO for 1 h followed by reperfusion for varying peri-
ods up to 24 h. In this model, ischemia-induced necrosis
is limited to the parietal and sensory-motor cortex, and
large infarcts are reproducibly generated in the MCA
territory. For each condition, the contralateral (C) hemi-
sphere was analyzed in parallel to control for physiologi-
cal events not specific to the infarcted (I) area. Tissue
extracts from infarcted and contralateral areas were
obtained, and the protein levels of the two main Rcan1
isoforms, Rcan1-1 and Rcan1-4, were measured by
immunoblot. The level of Rcan1-4 in the infarcted area
of the brain, where the occlusion took place, was
increased relative to the contralateral area of sham-oper-
ated animals (Figure 1). Increased Rcan1-4 expression
was noticeable after 5 h reperfusion and was very pro-
nounced after 24 h (Figure 1A, panel i lane 9). Parallel
analysis showed that in most cases the expression of the
Rcan1-1 isoform varied only slightly throughout the I/R
injury period (Figure 1A, panel i), although in some
experiments a slight decrease in the levels of Rcan1-1
protein was seen in the infarcted area after the longer
reperfusion periods (5 and 24 h). a-Tubulin protein
levels generally remained constant, although a slight
decline was observed in some experiments after 24 h
reperfusion, possibly as a result of damage to the
ischemic tissue (Figure 1B, panel ii).
Transcript levels of Rcan1-4 and inflammatory cytokines
are increased in the infarcted region after rat brain
ischemia/reperfusion injury
Rcan1-4 mRNA expression in the same brain ischemia
model was determined by real time qRT-PCR, together
with the mRNA expression levels of the proinflamma-
tory cytokines IL-1b, TNFa and interleukin 6 (IL-6) and
the proinflammatory gene cyclo-oxygenase 2 (Cox-2).
Rcan1-4 mRNA in the infarcted area was induced 2 h
after I/R injury (Figure 1B), preceding the increase in
Rcan1-4 protein; Rcan1-4 mRNA expression levels in
the contralateral area were unchanged. Expression levels
of the inflammatory markers in the infarcted area were
also specifically increased after 2 h reperfusion and this
increase was maintained at 5 h (Figure 1B, i to iv). A
basal elevation in inflammatory marker expression in
the infarcted area in the absence of I/R was probably
due to meningeal membrane rupture during the experi-
mental procedure. This increased inflammatory marker
expression above the levels obtained in sham-operated
animals agrees with published reports on other models
of stroke (reviewed in [30]).
Rcan1-4 is induced in GFAP positive astrocytes in vivo
We next investigated the cellular location of the
increased Rcan1 protein expression in response to brain
I/R injury, using an anti-Rcan1 antibody that recognizes
Rcan1-1 and Rcan1-4 isoforms [26]. After 24 h, Nissl
staining of coronal sections detected a hypochromatic
area in the infarcted neocortex, indicating neuronal
injury (Figure 2A). The location of Rcan1 expression in
relation to the injury site was analyzed by parallel
immunohistochemical staining on adjacent sections. In
addition, we stained for GFAP. In response to injury,
astrocytes at the wound boundary migrate to repair the
area. It is well established that astrocytes undergo a
reactive process in response to different kinds of brain
injury, such as ischemia and neurodegenerative diseases
[6,31-33]. The reactive astrocyte phenotype is character-
ized by cellular hypertrophy, hyperplasia and increased
expression of GFAP. At 24 h after early reperfusion,
immunostaining with different anti-GFAP antibodies
detected increased numbers of GFAP-positive cells in
the neocortex surrounding the injured tissue (Figure
2B). Colocalization of Rcan1 in the majority of GFAP-
positive cells around the infarct was confirmed by
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double immunostaining with goat anti-GFAP and rabbit
polyclonal anti-Rcan1 antibodies (Figure 2C). These
results agree broadly with a recent study describing
Rcan1 protein accumulation in neuronal and astroglial
cells, in which, as here, the antibody used for immuno-
histochemistry recognizes an Rcan1 C-terminal peptide
common to both isoforms, [23].
Cortical murine astrocytes express Rcan1-4 protein and
mRNA in response to hypoxia plus glucose deprivation
To examine the effect of ischemia on astrocyte Rcan1-4
expression, highly pure cultures (> 98%) of primary
murine astrocytes were subjected to periods of hypoxia
(3% O2) combined with glucose deprivation (HGD). For
comparison, cells were treated with phorbol ester (phor-
bol 12-myristate 13-acetate) plus calcium ionophore
A23187 (PIo); Rcan1-4 expression in PIo-treated astro-
cytes is maximal after 4 h [28], although at this time
NFATc3 protein appears as a slower migrating form
(Figure 3A, lane 2). Compared with PIo, HGD provoked
a more rapid and transient accumulation of Rcan1-4
protein, with levels increasing significantly within 1 h of
HGD in rat and mouse astrocytes and beginning to
diminish after 4 h (Figure 3A, B). A similar profile was
observed for Rcan1-4 mRNA, with expression maximal
after 60 minutes HGD, and diminishing to levels similar
to those in non-stimulated cells after 4 h (Figure 3C).
HGD treatment also induced dephosphorylation of
NFATc3 protein, observed as a faster migrating band on
immunoblot (Figure 3A).
Western blot analysis of NFAT proteins is difficult to
interpret, since most NFAT members exist as multiple
isoforms. In the case of NFATc3, there are at least four
mouse isoforms (according to the Ensemble database),
with at least three of them in the range of 1060 to 1076
amino acids. These NFATc3 isoforms all contain the
epitope used to raise the antibody used here; therefore
to differentiate them we carried out immunoblot analy-
sis on 6% SDS-PAGE gels, which were run until the 97
kDa marker approached the bottom of the gel in order
to better resolve high molecular weight proteins (Figure
4A). This analysis shows that the antibody recognizes a
number of bands that might correspond to the different
mouse NFATc3 isoforms. To confirm that the bands we
are studying correspond to NFATc3, we pretreated
mouse astrocyte primary cultures for 1 h before HGD
Figure 1 Regulator of calcineurin (Rcan)1-4 protein and mRNA expression increase at sites of transient focal brain ischemia,
paralleling increases in inflammatory cytokine mRNA levels. (A), panel (i) Representative immunoblot showing expression of endogenous
Rcan1-1 and Rcan1-4 proteins in infarcted cortical tissue (I) and the corresponding region of the contralateral hemisphere (C) of rats subjected to
middle cerebral artery occlusion (MCAO) for 1 h followed by reperfusion for the indicated times. Sh = sham operated animals. A total of 100 μg
protein was analyzed per lane. Panel (ii), band density quantification from four independent experiments as in (A), normalized to a-tubulin. (B)
Histograms showing relative quantification of mRNA expression by TaqMan real time qRT-PCR. Rat mRNAs for Rcan1-4 (i), TNF a (ii), IL-6 (iii) and
Cox-2 (iv) were amplified from total RNA from infarcted and corresponding contralateral hemispheres of rats subjected to MCAO (1 h) followed
by reperfusion (I/R) as indicated. Transcript amounts are normalized to 18S rRNA, and are expressed relative to contralateral samples from sham-
operated animals after reperfusion for 5 h (Sh). Real time qPCR reactionwas conducted in triplicate for each condition, and data are the means ±
SD of four experiments. **P < 0.01, *P < 0.05 (analysis of variance (ANOVA)) versus contralateral Sh samples.
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treatment with the calcineurin phosphatase inhibitor
cyclosporin A (CsA). CsA prevented the appearance of
the faster migrating bands after HGD treatment (Figure
4A). Furthermore, CsA changed the mobility pattern in
non-stimulated cells toward slower migrating forms.
Rcan1-4 protein expression modulates induced Cox-2
expression in primary astrocytes
To further analyze the potential role of Rcan1-4 protein
in astroglial cell behavior, we infected three independent
primary astrocyte cultures with an adenoviral vector
bicistronically encoding Rcan1-4 plus green fluorescent
protein (Ad Rcan1-4) or a control vector encoding GFP
alone (Ad GFP) [15]. Total cell proteins were separated
on 6% SDS-PAGE gels. Rcan1-4 overexpression in pri-
mary astrocytes caused the appearance of slower migrat-
ing forms of NFATc3 (Figure 4B), which match the
NFATc3 forms observed in cells pretreated with CsA
(Figure 4A). These results thus indicate that Rcan1-4
accumulation inhibits CN signaling by preventing NFAT
dephosphorylation. Our previous work demonstrated
that primary astrocytes respond to PIo treatment with a
marked induction of Cox-2 protein expression [28].
Adenoviral overexpression of Rcan1-4 in primary
Figure 2 Regulator of calcineurin 1 (Rcan1) expression colocalizes with glial fibrillary acidic protein (GFAP)-positive cells during
transient focal brain ischemia. Coronal brain sections of animals subjected to 1 h middle cerebral artery occlusion (MCAO) followed by 24 h
blood reperfusion. (A) Nissl staining revealing a hypochromatic area of ischemic tissue in the infarcted (I) neocortex. (B) Immunohistochemistry
showing expression of GFAP protein (red) in the contralateral hemisphere (a) and the infarcted region (b). Nuclei are revealed by staining
adjacent sections with TO-PRO 3 (blue; c and d). (C) Immunohistochemistry showing the GFAP-positive area around the infarcted brain region.
The boxed region is magnified in the lower panels: (a) GFAP immunostaining (red); (b) TO-PRO 3 nuclear staining (blue); (c) Rcan1
immunostaining (green); (d) overlay of (a-c). Yellow indicates GFAP-Rcan1 colocalization.
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Figure 3 Hypoxia (3%) and glucose deprivation induces regulator of calcineurin (Rcan)1-4 protein and mRNA expression in primary
cortical murine astrocytes. (A, B) Immunoblots showing endogenous Rcan1-4, nuclear factor of activated T cells (NFAT)c1 and NFATc3 protein
expression, with a-tubulin and PSF (PTB-associated splicing factor) expression detected as loading controls. (A) Rat primary cortical astrocytes
were non-stimulated (ns), treated with phorbol ester (phorbol 12-myristate 13-acetate) plus A23187 calcium ionophore (PIo) (4 h) as a positive
control, or subjected to combined hypoxia (3% O2) and glucose deprivation (HGD) for 1 to 6 h. (B) Mouse primary astrocyte cultures were non-
stimulated (ns) or subjected to HGD for 30 minutes to 4 h. (C) Rcan 1-4 mRNA was quantified by TaqMan real time qRT-PCR on total RNA from
primary cortical mouse astrocytes stimulated as in (B). Transcript amounts are normalized to 18S rRNA and TATA-binding protein (TBP)
endogenous controls, and are expressed relative to the level in non-stimulated control cells (ns). Data are the means ± SD of triplicate real time
qRT-PCR determinations for each condition; n = 4. **P < 0.01 (analysis of variance (ANOVA)) versus ns.
Figure 4 Cyclosporin A (CsA) pretreatment and regulator of calcineurin (Rcan)1-4 overexpression cause the appearance of slower
migrating nuclear factor of activated T cells (NFAT)c3 forms on SDS-PAGE. (A, B) Total cell lysates were separated on 6% SDS-PAGE gels
and immunoblotted with anti-NFATc3 antibody. Ponceau stainings of membranes are presented as loading controls. (A) Mouse primary astrocyte
cultures were either left without pretreatment or were pretreated with CsA for 1 h as indicated. Cells then were left non-stimulated (ns) or were
subjected to hypoxia and glucose deprivation (HGD) for 30 minutes to 4 h. (B) Three independent mouse astrocyte cultures (A-C) were infected
with adenovirus bicistronically encoding green fluorescent protein (GFP) plus Rcan1-4 (Ad Rcan1-4) or encoding GFP alone (Ad GFP). Samples
were run in parallel on 10% gels to analyze Rcan1-4 expression and to monitor GFP expression as a control of infection. Immunoblots show the
effect of Ad Rcan1-4 infection on Rcan1-4 protein expression and NFATc3 electrophoretic mobility.
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astrocytes reduced the amount of Cox-2 induced by PIo
by 30% (Figure 5B, C). Consistently, primary astrocytes
deficient for Rcan1 expressed increased amounts of
Cox-2 protein in response to this treatment (data not
shown). These data are in line with the induced Cox-2
transcript expression in brain after I/R injury (Figures 1
and 5).
Rcan1 gene deletion increases inflammatory gene
expression and infarct volume after transient focal
cerebral ischemia in mice
To investigate the precise role of Rcan1 expression after
brain I/R injury we compared injured brain areas in WT
and Rcan1 KO mice. For this, we first characterized the
procedure for MCAO, previously described for rat, in
the mouse. Transient focal cerebral ischemia (90 min-
utes) was produced in WT and KO mice in the C57/
BL6 genetic background. In the brains of Rcan1 KO
mice, I/R injury was accompanied by a more pro-
nounced increase in the mRNA expression of inflamma-
tory markers. After 5 h reperfusion, the increases in the
expression of TNFa, IL-6, IL-1b and Cox-2 in WT mice
were comparable to those encountered in the rat model
(Figure 1 and 6). Infarcted cortical tissue extracts from
Rcan1 WT and KO mice showed similar levels of CN
activity toward the specific substrate RII phosphopeptide
(Figure 6B), suggesting that Rcan1 deficiency does not
significantly affect soluble CN phosphatase activity in
brain cortices.
We next analyzed the functional consequence of
Rcan1 deletion in this stroke model. The extent of I/R
injury after 48 h reperfusion was determined from the
infarct volume, measured from serial Nissl-stained sec-
tions. Our results show that infarct volumes were signif-
icantly larger in Rcan1 KO mice compared with WT
(Figure 6). The MCAO procedure was not associated
with animal death in either animal genotype.
Discussion
In this study we report that Rcan1-4 protein and mRNA
levels are increased after brain ischemia/reperfusion
injury in vivo. Lack of Rcan1 is associated with larger
infarct volume and higher expression of inflammation
associated genes. Rcan1 expression after I/R injury
occurs mainly in astroglial cells, correlating with the
increased Rcan1-4 mRNA and protein expression
observed in murine astrocytes subjected to hypoxia plus
glucose deprivation. Consistent with the effect of Rcan1
deletion in the I/R in vivo model, overexpression of exo-
genous Rcan1-4 inhibits the production of the inflam-
matory marker Cox-2, while lack of Rcan1 augments
this marker. These results support a protective role for
Rcan1 during the inflammatory brain response during
stroke.
Our immunoblot analyses indicate that the Rcan1
isoform induced after I/R is Rcan1-4 and not Rcan1-1
(Figure 1). Our data also show that the increased
expression occurs mainly in GFAP-positive cells around
Figure 5 Regulator of calcineurin (Rcan)1-4 protein downregulates expression of the proinflammatory gene Cox-2 in mouse primary
astrocytes. (A) Astrocytes were infected with adenovirus bicistronically encoding green fluorescent protein (GFP) plus Rcan1-4 (Ad Rcan1-4) or
encoding GFP alone (Ad GFP). Immunoblots show the effect of Ad Rcan1-4 infection on Rcan1-4 protein expression and nuclear factor of
activated T cells (NFAT)c3 electrophoretic mobility. a-Tubulin and PSF (PTB-associated splicing factor) were used as endogenous loading controls
and GFP as a marker of equal infection. (B) Rcan1-4 overexpression inhibits astrocyte cyclo-oxygenase 2 (Cox-2) induction. At 48 h post infection,
cells were quiesced, and then stimulated with phorbol ester (phorbol 12-myristate 13-acetate) plus A23187 calcium ionophore (PIo) as indicated.
Blots show expression of Cox-2 and Rcan1-4 protein. Identical concentrations of adenoviral particles were used for each infection in all
experiments. (C) Densitometry analysis of PIo-Cox2 induction. Data are the means ± SD of densitometry value of n = 4 experiments. The figure
of 100% is the Cox2 expression achieved by PIo stimulation for 6 h in Ad GFP cells. PIo-induced Cox2 expression in Ad Rcan1-4 cells is 72 ±
11%. All values are corrected relative to the loading control a-tubulin.
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the infarcted area. Using a different focal brain ischemia
model, a recent report showed upregulation of Rcan1
protein in both the neural and glial compartments
around the infarcted area [23]. This apparent discre-
pancy cannot be easily explained; however, in our
experiments, in which staining was compared with the
equivalent contralateral area, differential Rcan1 labeling
was detected only in GFAP-positive cells. For our analy-
sis of Rcan1 cellular localization in the rat MCAO I/R
model we used a polyclonal antibody that recognizes
both Rcan1-1 and Rcan1-4. While this antibody clearly
distinguishes the two isoforms on immunoblots, from
their different molecular masses, it cannot differentiate
them by immunofluorescence staining. In our analyses,
the Rcan1 antibody also stained NeuN-positive cells in
the infarcted area, although this staining was no stron-
ger than that observed in the contralateral area of sham-
operated animals (data not shown). Thus increased
Figure 6 Expression of ischemia/reperfusion-inducible inflammatory markers and infarct volume are increased in regulator of
calcineurin (Rcan)1 knockout mice after transient focal cerebral ischemia in mice. (A) TNFa, IL-6 and Cox-2 mRNAs were amplified by
TaqMan real time qRT-PCR from total RNA obtained from infarcted (I) and corresponding contralateral hemispheres (C) of wild-type (WT) (black
columns) and Rcan1 knockout (KO) (gray columns) mice subjected to 90 minutes middle cerebral artery occlusion (MCAO) followed by 5 h
reperfusion. Transcript amounts are normalized to TATA-binding protein (TBP) as an endogenous control, and are expressed relative to the level
in contralateral samples from sham-operated animals after reperfusion for 5 h (sham). Real time qPCR was conducted in triplicate for each
condition, and data are the means ± SD of four experiments. **P < 0.01, *P < 0.05 (ANOVA) versus contralateral sham samples. (B) Calcineurin
(CN) enzyme activity against phosphopeptide RII measured in brain cortices from Rcan1 WT and Rcan1 KO mice. ns = non-significant (Student’s t
test). (C) Mice were subjected to 90 minutes MCAO followed by 48 h blood reperfusion, and infarct volumes were estimated by Cavalieri’s
principle from Nissl-stained serial coronal sections. (i) Representative stacks of six Nissl-stained sections, revealing a larger hypochromatic area of
ischemic tissue in the infarcted neocortex of Rcan1 KO animals. (ii) Quantification of cerebral infarct volume in WT and Rcan1 KO mice. The
percentage of tissue volume infarcted in the right hemisphere = (1 - (RN/L) ×100), where RN is spared tissue in right (infarcted) hemispheres and
L is the left (contralateral) hemisphere; cerebral tissue volume is expressed in mm3. Data are means ± SEM. n = 7 per genotype; *P < 0.05.
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Rcan1 reactivity was restricted to GFAP-positive cells, in
agreement with the GFAP-positive staining seen by Cho
et al. [23]. Moreover, the immunoblots indicate that the
induced expression is due to Rcan1-4, with no signifi-
cant change in Rcan1-1 (Figure 1). We therefore con-
clude that at the times examined the increased Rcan1
immunostaining in brain slices is due mostly to the
expression of Rcan1-4 in glial cells surrounding the
infarcted tissue. Confirmation of this must await the
availability of Rcan1-1 and Rcan1-4 specific antibodies
for immunohistochemistry analysis.
Treatment of astrocytes with PIo induced the appear-
ance of a slower migrating band for NFATc3 protein
(Figure 3A). Calcineurin activity has been classically esti-
mated from the NFAT phosphorylation status [34,35].
We and others have shown that, in response to PIo,
other NFAT proteins such as NFATc2 shift to a faster
migrating band that has been considered the depho-
sphorylated form [13,36]. We also showed previously
that NFATc1, c2, c3 and c4 are present in astrocyte cul-
tures, with NFATc3 the most abundant member [28].
Pretreatment of these cells with CsA retards the gel
mobility of all NFAT members analyzed. The unique
response of NFATc3 to PIo induction has been reported
previously by ourselves in astrocytes and by Urso et al.
in Jurkat cells. These authors detected a slower migrat-
ing NFATc3 band at the same time (1 h) after exposure
to PIo as we observe in astrocytes. This slower migrat-
ing form of NFATc3 might be a phosphorylated form
generated by the action of PIo-induced kinases. Further
experiments would be needed to demonstrate this
hypothesis. To confirm that PIo induction in astrocytes
efficiently translocates NFATc3 protein to the nucleus,
we analyzed nuclear and cytosolic fractions (data not
shown), detecting NFATc3 protein in the nuclear frac-
tion of astrocytes treated with PIo for 1 h. When cells
are pretreated with CsA, slower migrating NFATc3
forms were generated that run above 190 kDa; these
NFATc3 forms accumulate in the cytosolic fraction and
are not observed in the nuclear extract. Notably, non-
stimulated astrocytes present NFATc3 proteins with
intermediate mobilities on western blot analysis.
An anti-neuroinflammatory action of Rcan1 is consis-
tent with inhibition of the CN signaling pathway. CN is
a central inflammatory regulator in many cell types. In
the brain, CN inhibitors such as CsA and FK506 have
been shown to reduce tissue damage in response to
stroke (reviewed in [37]). In line with our findings,
Rcan1-4 expression has been shown to attenuate inflam-
matory and angiogenic responses [14,15,38], and a pro-
tective effect has also been proposed against oxidative
stress [39]. Furthermore, targeted overexpression of con-
stitutively active CN A in astrocytes has been reported
to protect against brain inflammatory injury, as
measured by negative regulation of inflammation hall-
marks such as lipopolysaccharide-inducible Cox-2 and
inducible NO synthase (iNOS) [40]. However, this study
did not examine the expression of Rcan1-4, which is
likely activated in response to the excess CN activity.
Further studies to define the mechanism of endogenous
modulation of CN activity will be important to deter-
mine how Rcan1 and CN influence the final outcome of
the neuroinflammatory process.
Our current results with Rcan1 KO mice are compati-
ble with Rcan1 downregulating the CN/NFAT signaling
pathway. This notion is further supported by the
appearance of slower migrating forms of endogenous
NFATc3 in astrocytes overexpressing exogenous Rcan1-
4 protein (Figures 4 and 5); these bands are very similar
to the high molecular NFATc3 bands observed in CsA-
treated cells (Figure 4). We suggest that these slower
mobility forms might be hyperphosphorylated NFATc3
proteins. Furthermore, in cells overexpressing Rcan1-4
there is a partial inhibition of PIo-induced expression of
the NFAT-dependent gene Cox-2 (Figure 5). The level
of inhibition is similar to that obtained with CsA, as we
previously described [28]. The potential of Rcan1 pro-
teins to inhibit CN signaling either by an effect on CN
phosphatase activity directly or by an action on the CN/
NFAT signaling pathway via other means has been the
focus of much controversy in the field. Rcan1 was ori-
ginally identified as a negative regulator of CN activity
[18,41-44]. However, other reports have shown that
Rcan1 might not always repress CN activity. For exam-
ple, heart tissue extracts form Rcan1 KO mice [45,46]
and extracts from rcn1-/- yeast (the Rcan1 homologue in
yeast) [43], display reduced CN activity, leading these
authors to conclude that Rcan1 proteins might facilitate
CN activity. Biochemical analysis has shown that the
specificity of signaling kinases and phosphatases toward
their targets is usually mediated by docking interactions
with substrates and regulatory proteins, and this is the
case with Rcan1 and CN. Martinez-Martinez et al.
recently showed that the inhibitory action of Rcan1 on
calcineurin-NFAT signaling results not only from the
inhibition of CN phosphatase activity, but also from
competition between NFAT and Rcan1 for binding to
the same docking site on calcineurin [47]. This competi-
tion for docking sites has been corroborated by another
group [48]. Therefore the inhibition of the CN-depen-
dent pathway might not be by direct inhibition of the
activity of the phosphatase CN. We previously showed
that CN is able to bind to endogenous Rcan1 proteins
in astrocytes (see [28]), indicating that a similar mechan-
ism might be operating in astrocytes. As we show in
Figure 6B, Rcan1 loss of function does not affect CN
enzymatic activity in brain cortices, indicating that in
our system the inhibitory action of Rcan1 on CN-NFAT
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signaling is not due to direct inhibition of CN phospha-
tase activity.
The appearance of reactive gliosis in the periphery of
the infarcted tissue is one of the most striking changes
occurring in the brain after ischemia [49]. Furthermore,
expression of constitutively active CN in astrocyte cul-
tures has been shown to mimic the phenotype and gene
transcription of activated astrocytes [50]. Although the
exact role of this pathway in astrocyte activation is not
completely understood, these findings suggest a scenario
in which Ca2+-initiated CN activation is instrumental in
the mounting of astrocyte inflammatory responses, with
Rcan1-4 expression subsequently induced as an auto
regulatory mechanism to prevent uncontrolled gliosis. It
will therefore be of interest to study the effect of tar-
geted glial-CN activation on the response to brain
injury.
Although the precise mechanism of glial Rcan1-4
upregulation during brain ischemia is unclear, our
results support an important contribution via hypoxia-
induced CN-NFAT signaling. Little is known about the
induction of CN-NFAT signaling by hypoxia, although
transcriptional regulation has been reported in pulmon-
ary arterial smooth muscle cells in response to chronic
hypoxia [51] and in neuronal cells as a response to CN
activation [52]. Rcan1-4 expression is a reliable marker
of NFAT-dependent transcription, and our in vitro
model of hypoxia plus glucose deprivation shows rapid
(1 h) induction of Rcan1-4 expression and NFATc3 pro-
tein dephosphorylation. We have observed a clear inhi-
bition of NFATc3 dephosphorylation by the CN
inhibitor CsA (data not shown). We can therefore con-
clude that HGD activates the CN-NFAT signaling path-
way in glial cells. However, other possible CN activators
include proinflammatory cytokines such as IL-1b,
TNFa, and IL-6, which are detected in the ischemic cor-
tex 1 h after MCAO [53]. Indeed, IL-1b has been
reported to activate the CN-NFAT pathway in highly
enriched astrocytes [54]. In our hands, IL-1b only
weakly induced Rcan1-4 expression in astrocytes, and
we conclude that the initial Rcan1-4 expression in pri-
mary cultures is likely due to the calcium surge asso-
ciated with the primary hypoxia. Consistent with an
early, direct response to hypoxia, we see Rcan1-4 after 1
h in the in vitro astrocyte HGD model. However, the in
vivo profile of Rcan1-4 expression in response to I/R
injury is slower, with accumulation evident at 5 h and
maximal expression detected at 24 h, the last time point
examined. This profile probably reflects the complex
multicellular environment of the intact brain, possibly
including a contribution from the second wave of
inflammatory cascades. The impact of other signaling
pathways on Rcan1-4 expression during brain I/R injury
is a possibility that should be pursued further.
Conclusions
Inflammatory responses to ischemia can be mounted in
response to one or various inflammatory stimuli, and
the specific responses will vary for each cell type within
the brain. Our data support a protective role for Rcan1
during the inflammatory response to stroke. Our results
underline the need to take account of the impact of
ischemia and its inflammatory consequences on the glial
compartment, and to understand how glial cells respond
to local ischemia in concert with the neurons they sup-
port. Improved understanding of non-neuronal mechan-
isms in ischemic injury promises novel approaches to
the treatment of acute ischemic stroke.
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